LAUSR

1 Gu Y, Qng Y, Li P et al. Fulminant type 1 diabetes in children: A multicenter study in China. J. Diabetes Res. 2017; 2017: 6924637. 2 Shiga K, Urakami T, Suzuki J et al. Fulminant type 1 diabetes mellitus in Japanese children and adolescents: MultiInstitutional Joint Research of the Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes. Endocr. J. 2018; 65: 795–803. 3 Saito D, Oikawa Y, Mizutani G et al. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes. Endocr. J. 2019; 66: 329–36. 4 Tsutsumi C, Imagawa A, Ikegami H et al. Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies. J. Diabetes Investig. 2012; 3: 62–9. 5 Baden MY, Imagawa A, Iwahashi H et al. Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus. Diabetol. Int. 2015; 7: 281–88.